Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chenglu Huang"'
Epidemiological Evidence Between Variants in Matrix Metalloproteinases-2, -7, and -9 and Cancer Risk
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMatrix metalloproteinases (MMPs), a kind of proteases, have a critical function in cancer occurrence, invasion, and migration. MMP gene variants (e.g., MMP-2, MMP-7, and MMP-9) can affect the biological functions of these enzymes and lead t
Externí odkaz:
https://doaj.org/article/d38a7c48d984410c8c70b4b32db7777b
Autor:
Zhilin Luo, Hong Zhang, Yajie Xiao, Rui Wang, Liping Zhang, Chenglu Huang, Yu Cao, Chao Sun, Yongtian Zhao, Hanqing Lin, Dongfang Wu, Tianhu Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immunotherapy alone or chemo-immunotherapy has recently been recommended for treating advanced lung carcinoma in patients without driver mutations. However, the efficacy of immunotherapy and molecular mechanism in large-cell lung cancer (LCLC) remain
Externí odkaz:
https://doaj.org/article/ab8a32de02134158b3248a2db7344b80
Autor:
Dingyue Liu, Chengzhang Zhao, Geyang Li, Zhini Chen, Suhong Wang, Chenglu Huang, Peixian Zhang
Publikováno v:
Functional Plant Biology; 2024, Vol. 51 Issue 5, p1-12, 12p
Publikováno v:
BioMed Research International. 2022:1-11
Background. A large amount of publications had reported the association between incidence of esophageal cancer (EC) and type 2 diabetes mellitus (T2DM) in the past decade. However, those papers’ results are inconsistent on relationships between T2D
Autor:
Tianhu Wang, Dongfang Wu, Yu Cao, Hanqing Lin, Zhilin Luo, Yajie Xiao, Chao Sun, Rui Wang, Chenglu Huang, Liping Zhang, Hong Zhang, Yongtian Zhao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Immunotherapy alone or chemo-immunotherapy has recently been recommended for treating advanced lung carcinoma in patients without driver mutations. However, the efficacy of immunotherapy and molecular mechanism in large-cell lung cancer (LCLC) remain
Objective We aimed to compare the dynamic differences of immunological parameters in severe and non-severe COVID-19. Methods In this study, the cytokine profiles and lymphocyte subsets of 70 patients (31 severe COVID-19 and 39 non-severe COVID-19) we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::698b6bd9d0dd8d5998bc4893d5f44eae
https://doi.org/10.21203/rs.3.rs-36753/v1
https://doi.org/10.21203/rs.3.rs-36753/v1